{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:49:33Z","timestamp":1791913773406,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008890","name":"University of Dundee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["223499 \/Z\/21\/Z"],"award-info":[{"award-number":["223499 \/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ekir.2026.107085","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:42:25Z","timestamp":1789666945000},"page":"107085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Opioid and Gabapentinoid Related Harms in CKD"],"prefix":"10.1016","volume":"11","author":[{"given":"Christopher H.","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shona","family":"Livingstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen N.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Colvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2026.107085_bib1","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"Mark","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2026.107085_bib2","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/ndt\/gfae048","article-title":"Global health inequalities of chronic kidney disease: a meta-analysis","volume":"39","author":"Duff","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.107085_bib3","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2026.107085_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2026.107085_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bja.2020.05.017","article-title":"Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland","volume":"125","author":"Torrance","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ekir.2026.107085_bib6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.kint.2021.03.041","article-title":"The prevalence of pain among patients with chronic kidney disease using systematic review and meta-analysis","volume":"100","author":"Lambourg","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107085_bib7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ackd.2005.03.008","article-title":"Chronic pain in end-stage renal disease","volume":"12","author":"Davison","year":"2005","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107085_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bja.2021.08.035","article-title":"Analgesic use and associated adverse events in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"128","author":"Lambourg","year":"2022","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ekir.2026.107085_bib9","first-page":"5","article-title":"The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice","volume":"21","author":"Murtagh","year":"2007","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.ekir.2026.107085_bib10","first-page":"93","article-title":"WHO guidelines for the use of analgesics in cancer pain","volume":"7","author":"Ventafridda","year":"1985","journal-title":"Int J Tissue React"},{"key":"10.1016\/j.ekir.2026.107085_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100321","article-title":"The epidemiology of regular opioid use and its association with mortality: prospective cohort study of 466 486 UK Biobank participants","volume":"21","author":"Macfarlane","year":"2020","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.ekir.2026.107085_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/2054358120910329","article-title":"Analgesic use in patients with advanced chronic kidney disease: a systematic review and meta-analysis","volume":"7","author":"Davison","year":"2020","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.ekir.2026.107085_bib13","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2215\/CJN.09910917","article-title":"Opioid analgesics and adverse outcomes among hemodialysis patients","volume":"13","author":"Ishida","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107085_bib14","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107085_bib15","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1681\/ASN.2019090904","article-title":"Hip fracture risk among hemodialysis-dependent patients prescribed opioids and gabapentinoids","volume":"31","author":"Vangala","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107085_bib16","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1681\/ASN.2017010098","article-title":"Opioid prescription, morbidity, and mortality in United States dialysis patients","volume":"28","author":"Kimmel","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107085_bib17","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2215\/CJN.00440119","article-title":"Associations of opioid prescriptions with death and hospitalization across the spectrum of estimated GFR","volume":"14","author":"Novick","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107085_bib18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1159\/000509451","article-title":"Mortality risk in chronic kidney disease patients transitioning to dialysis: impact of opiate and non-opiate use","volume":"51","author":"You","year":"2020","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2026.107085_bib19","doi-asserted-by":"crossref","first-page":"21730","DOI":"10.18632\/aging.103978","article-title":"Frailty modifies the association between opioid use and mortality in chronic kidney disease patients with diabetes: a population-based cohort study","volume":"12","author":"Lee","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ekir.2026.107085_bib20","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/TP.0000000000002057","article-title":"Opioid prescription, morbidity, and mortality in US transplant recipients","volume":"102","author":"Abbott","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2026.107085_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/j.ajkd.2019.12.010","article-title":"Association of opioids and nonsteroidal anti-inflammatory drugs with outcomes in CKD: findings from the CRIC (chronic renal insufficiency cohort) study","volume":"76","author":"Zhan","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107085_bib22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ki.2013.136","article-title":"A history of chronic opioid usage prior to kidney transplantation may be associated with increased mortality risk","volume":"84","author":"Barrantes","year":"2013","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2026.107085_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/fampra\/cmy130","article-title":"Recognizing misclassification bias in research and medical practice","volume":"36","author":"Pham","year":"2019","journal-title":"Fam Pract"},{"key":"10.1016\/j.ekir.2026.107085_bib24","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2016.16435","article-title":"Confounding by indication in clinical research","volume":"316","author":"Kyriacou","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.107085_bib25","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/ckj\/sfaa242","article-title":"Pharmacoepidemiology for nephrologists (part 2): Potential biases and how to overcome them","volume":"14","author":"Fu","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.107085_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/oxfordjournals.pubmed.a024546","article-title":"The public health uses of the Scottish Community Health Index (CHI)","volume":"18","author":"Womersley","year":"1996","journal-title":"J Public Health Med"},{"key":"10.1016\/j.ekir.2026.107085_bib28","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/ndt\/gfz142","article-title":"Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project","volume":"35","author":"Runesson","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.107085_bib29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/bcpt.13127","article-title":"Prevalence of renally inappropriate medicines in older people with renal impairment - A cross-sectional register-based study in a large primary care population","volume":"124","author":"Schmidt-Mende","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ekir.2026.107085_bib30","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2026.107085_bib31","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107085_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/jamiaopen\/ooad078","article-title":"Determining prescriptions in electronic healthcare record data: methods for development of standardized, reproducible drug codelists","volume":"6","author":"Graul","year":"2023","journal-title":"JAMIA Open"},{"key":"10.1016\/j.ekir.2026.107085_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13012-022-01251-2","article-title":"Assessing the impact of a national clinical guideline for the management of chronic pain on opioid prescribing rates: a controlled interrupted time series analysis","volume":"17","author":"H\u00e9bert","year":"2022","journal-title":"Implement Sci"},{"key":"10.1016\/j.ekir.2026.107085_bib34","series-title":"SIGN 136: management of chronic pain: a national clinical guideline","year":"2013"},{"key":"10.1016\/j.ekir.2026.107085_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.16839","article-title":"Assessment of prescription analgesic use in older adults with and without chronic kidney disease and outcomes","volume":"3","author":"Han","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ekir.2026.107085_bib37","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s41999-024-00953-8","article-title":"Rising to the challenge of defining and operationalising multimorbidity in a UK hospital setting: the ADMISSION research collaborative","volume":"15","author":"Cooper","year":"2024","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.ekir.2026.107085_bib38","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ckj\/sfaa244","article-title":"Pharmacoepidemiology for nephrologists (part 1): Concept, applications and considerations for study design","volume":"14","author":"Trevisan","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.107085_bib39","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jamainternmed.2018.4749","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with outcomes after acute kidney injury","volume":"178","author":"Brar","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ekir.2026.107085_bib40","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ekir.2026.107085_bib41","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00125-012-2668-0","article-title":"Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs","volume":"55","author":"Colhoun","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.ekir.2026.107085_bib42","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/pds.4327","article-title":"Modelling cumulative exposure for inference about drug effects in observational studies","volume":"26","author":"Farran","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ekir.2026.107085_bib43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00125-014-3456-9","article-title":"Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis","volume":"58","author":"Levin","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.ekir.2026.107085_bib44","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.2215\/CJN.00650117","article-title":"Statistical methods for modeling time-updated exposures in cohort studies of chronic kidney disease","volume":"12","author":"Xie","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107085_bib45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2307\/2529360","article-title":"On the treatment of grouped observations in life studies","volume":"33","author":"Thompson","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.ekir.2026.107085_bib46","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ije\/dyaa213","article-title":"Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations","volume":"50","author":"Tennant","year":"2021","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ekir.2026.107085_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078226","article-title":"How to use directed acyclic graphs: guide for clinical researchers","volume":"388","author":"Feeney","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.ekir.2026.107085_bib48","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1002\/sim.10260","article-title":"A comparison of variance estimators for logistic regression models estimated using generalized estimating equations (GEE) in the context of observational health services research","volume":"43","author":"Austin","year":"2024","journal-title":"Stat Med"},{"key":"10.1016\/j.ekir.2026.107085_bib49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.0006-341X.2001.00120.x","article-title":"Akaike's information criterion in generalized estimating equations","volume":"57","author":"Pan","year":"2001","journal-title":"Biometrics"},{"key":"10.1016\/j.ekir.2026.107085_bib50","series-title":"R: a Language and Environment for Statistical Computing","year":"2024"},{"key":"10.1016\/j.ekir.2026.107085_bib51","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ekir.2026.107085_bib52","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ekir.2026.107085_bib53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.ajkd.2021.11.007","article-title":"Higher-dose gabapentinoids and the risk of adverse events in older adults with CKD: a population-based cohort study","volume":"80","author":"Muanda","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107085_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193134","article-title":"Gabapentin dose and the 30-day risk of altered mental status in older adults: a retrospective population-based study","volume":"13","author":"Fleet","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2026.107085_bib55","series-title":"NICE CG193 Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain","year":"2021"},{"key":"10.1016\/j.ekir.2026.107085_bib56","series-title":"SIGN 173: management of chronic pain (Part 1)","year":"2025"},{"key":"10.1016\/j.ekir.2026.107085_bib57","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(11)60937-9","article-title":"Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial","volume":"378","author":"Hill","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2026.107085_bib58","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0140-6736(09)62164-4","article-title":"Group cognitive behavioural treatment for low-back pain in primary care: a randomised controlled trial and cost-effectiveness analysis","volume":"375","author":"Lamb","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2026.107085_bib59","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.2016.2323","article-title":"Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial","volume":"315","author":"Cherkin","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.107085_bib60","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/AJP.0b013e318219a933","article-title":"A comparative study of 2 manual-based self-help interventions, acceptance and commitment therapy and applied relaxation, for persons with chronic pain","volume":"27","author":"Thorsell","year":"2011","journal-title":"Clin J Pain"},{"key":"10.1016\/j.ekir.2026.107085_bib61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12875-017-0608-2","article-title":"Barriers and facilitators to use of non-pharmacological treatments in chronic pain","volume":"18","author":"Becker","year":"2017","journal-title":"BMC Fam Pract"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926033176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926033176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:09:10Z","timestamp":1791911350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024926033176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2468024926033176"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2026.107085","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Opioid and Gabapentinoid Related Harms in CKD","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.107085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}],"article-number":"107085"}}